Stock market anomaly: Ark Pharmacy (06086) rebounded more than 20% on the second day of listing, still falling by 30% compared to the IPO price. It has accumulated losses of nearly 0.9 billion yuan in the past three years.

According to the Zhītōng Cáijīng app, Ark Pharmacy (06086) fell over 44% yesterday and rebounded over 20% in early trading today. The current stock price still fell 30% from the offer price. As of press time, it rose 17%, to HKD 5.3, with a turnover of HKD 11.1438 million. It is reported that Ark Pharmacy focuses on the management of chronic diseases (such as hypertension, cardiovascular, respiratory system, etc.), provides comprehensive and all-round management services for chronic diseases, and provides comprehensive medical services and online retail pharmacy services through the Jianke platform. According to the information from Zhuó Shí Zīxún, based on the average monthly active users in 2023, the company is China's largest online chronic disease management platform.

Zhitong FinanceJul 9 23:57 ET

Why can't Farlong Pharmaceuticals (06086) tell the story of H2H despite the dark market crash and the waist-cutting of the listing?

Wearing the title of "the largest internet plus-related chronic disease management platform in China", Ark Pharmacy (06086) officially listed on the Hong Kong Stock Exchange on July 9th. However, this title seems to have brought little benefit to the company, as the opening price dropped by nearly 50%, showing the "other passion" from the capital markets.

Zhitong FinanceJul 9 07:00 ET

Hong Kong stocks closed (07.09) | HSI flat, Apple suppliers and semiconductor stocks strong throughout the day, cnbm (03323) plummeted 13% after warning of earnings.

In the morning trading, the three major Hong Kong stock indices showed weak volatility. They all rose and turned red at noon, but then struggled to rise. The Hang Seng Index and the National Index successively fell, only the Hang Seng China Enterprise Index achieved growth.

Zhitong FinanceJul 9 04:44 ET

Arctic Vision's IPO First Offer Price is HKD 4.68, 42.79% lower than the offer price.

Kingwu Finance | Ark Cloud Health (06086) debuted at HK$4.68, a 42.79% discount to the offer price, with a pre-market turnover of 3.1385 million shares and a turnover of HK$15.2637 million, excluding handling fees. Each hand consists of 500 shares, resulting in a book loss of HK$1,750. According to the previous offer results, the price was set at HK$8.18 per share, with a total capital-raising amount of HK$1.95 billion and a net amount of approximately HK$67.09 million. Each hand consists of 500 shares, with a 40.04% chance of winning one hand when subscribing for four hands. During the Hong Kong public offering stage, 4,371 valid applications were received for subscription, which was 16.63 times the subscription amount; international distribution was

金吾財訊Jul 8 21:26 ET

On the first day of the new stock, Ark Pharmacy (06086) was listed and opened at 42.79% lower in the morning.

According to the news from CITIC Securities News APP, Ark Pharmacy (06086) has gone public. The announcement shows that the price per share is HKD 8.18, a total of 23.8 million shares are issued, and 500 shares per lot. The net amount raised is approximately HKD 67.09 million. As of the time of writing, the stock has fallen by 42.79%, to HKD 4.68, with a trading volume of HKD 15.2637 million. According to the information from Zhuo Shi Consulting, the group is the largest online platform for chronic disease management in China based on the average monthly active users in 2023. The group focuses on chronic disease management to meet the needs of patients with chronic diseases such as hypertension, cardiovascular, and respiratory syste.

Zhitong FinanceJul 8 21:25 ET

Fangzhou Shares Down 43% in Pre-Market Session on HK Debut

Dow JonesJul 8 21:21 ET